Company / Cost of Revenue
PROCEPT BioRobotics Corp Cost of Revenue History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$111.8M
FY2025
5-year range
$18.6M / $111.8M
FY2021-FY2025
Trend
+28.0%
vs FY2024
Sector context
#88 of 110
Health Care
What the data says
PROCEPT BioRobotics Corp's cost of revenue of $112M is lower than 80% of companies in the Health Care sector (FY2025). Cost of Revenue has increased for 5 consecutive years, from $9M in FY2020 to $112M in FY2025.
Based on SEC 10-K filings.
$112M in FY2025 with a 5-year CAGR of +65.6%.
Increased from $65M to $112M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +43.4%
- 5-Year CAGR
- +65.6%
- 10-Year CAGR
- -
Sector benchmark
Top 20% in Health CareTop 20% of 110This company $111.8M Sector average $11.5B
▼
-99.0% below sector average
Key checks
Key Insights
- PROCEPT BioRobotics Corp's cost of revenue has grown for 5 consecutive years.
- 5-year CAGR of +65.6%, indicating consistent growth.
- In FY2025, cost of revenue increased 28.0% year-over-year.
- Ranks #88 out of 110 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $111.8M | +28.0% |
| FY2024 | $87.4M | +34.2% |
| FY2023 | $65.1M | +71.7% |
| FY2022 | $37.9M | +103.8% |
| FY2021 | $18.6M | +107.4% |
| FY2020 | $9.0M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026